Group A streptococci from invasive-disease episodes in poland are remarkably divergent at the molecular level

Journal of Clinical Microbiology

Volumn 44, Issue 11, 2006, Pages 3975-3979

  Szczypa, Katarzyna ^a   Sadowy, Ewa ^a   Izdebski, Radoslaw ^a   Strakova, Lenka ^b   Hryniewicz, Waleria ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; EXOTOXIN; LEVOFLOXACIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; MIKAMYCIN B; PENICILLIN G; SPIRAMYCIN; TELITHROMYCIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; EMM GENE; EMM1 GENE; EMM12 GENE; FEMALE; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MALE; MOLECULAR GENETICS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; POLAND; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPEA GENE; SPEB GENE; SPEC GENE; SPEF GENE; SSA GENE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

SPEA; STREPTOCOCCUS SP. 'GROUP A';

EID: 33750939448     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01163-06     Document Type: Article

References (32)

1. Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D. E. Low, A. McGeer, and M. Kotb. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:3523-3534.
2. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing, fifteenth informational supplement; M100-S15. Cinical and Laboratory Standards Institute, Wayne, Pa.
3. Comité de l'Antibiogramme de la Société Française de Microbiologie. 1996. Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. Statement 1996 CA-SFM. Zone sizes and MIC breakpoints for non-fastidious organisms. Clin. Microbiol. Infect. 2:45-49.
4. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
5. Davies, D. H., A. McGeer, B. Schwartz, K. Green, D. Cann, A. E. Simor, and D. E. Low. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335:547-554.
6. Descheemaeker, P. F., M. Van Loock, P. Hauchecorne, P. Vandamme, and H. Goossens. 2000. Molecular characterisation of group A streptococci from invasive and noninvasive disease episodes in Belgium during 1993-1994. J. Med. Microbiol. 49:467-471.
7. Efstratiou, A. 2000. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45:3-12.
8. Ekelund, K., J. Darenberg, A. Norrby-Teglund, S. Hoffmann, D. Bang, P. Skinhøj, and H. B. Konradsen. 2005. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J. Clin. Microbiol. 43:3101-3109.
9. Ekelund, K., P. Skinhøj, J. Madsen, and H. B. Konradsen. 2005. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J. Clin. Microbiol. 43:1789-1796.
10. Enright, M. C., B. G. Spratt, A. Kalia, J. H. Cross, and D. B. Bessen. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69:2416-2427.
11. Facklam, R., B. Beall, A. Efstratiou, A. Efstratiou, V. Fischetti, D. Johnson, E. Kaplan, P. Kriz, M. Lovgren, D. Martin, B. Schwartz, A. Totolian, D. Bessen, S. Hollingshead, F. Rubin, J. Scott, and G. Tyrrell. 1999. emm typing and validation of provisional M types for group A streptococci. Emerg. Infect. Dis. 5:247-253.
12. Factor, S. H., O. S., Levine, B. Schwartz, L. H. Harrison, M. M. Farley, A. McGeer, and A. Schuchat. 2003. Invasive group A streptococcal disease: risk factors for adults. Emerg. Infect. Dis. 9:970-977.
13. Ho, P. L., D. R. Johnson, A. W. Y. Yue, D. N. C. Tsang, T. L. Que, B. Beall, and E. L. Kaplan. 2003. Epidemiological analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong. J. Clin. Microbiol. 41:937-942.
14. Hoge, C. W., B. Schwartz, D. F. Talkington, R. F. Breiman, E. M. MacNeill, and S. J. Englender. 1993. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA 269:384-389.
15. Hsueh, P.-R., J.-J. Wu, P.-J. Tsai, J.-W. Liu, Y.-C. Chuang, and K.-T. Luh. 1998. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin. Infect. Dis. 26:584-589.
16. Jasir, A., and C. Schalén. 2005. Strep-EURO: progress in analysis and research into severe streptococcal disease in Europe, 2003-2004. Eurosurveillance 10:60-61.
17. McGregor, K. F., B. G. Spratt, A. Kalia, A. Bennett, N. Bilek, B. Beall, and D. E. Bessen. 2004. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J. Bacteriol. 186:4285-4294.
18. McNeil, S. A., S. A. Halperin, J. M. Langley, B. Smith, A. Warren, G. P. Sharratt, D. M. Baxendale, M. A. Reddish, M. C. Hu, S. D. Stroop, J. Linden, L. F. Fries, P. E. Vink, and J. B. Dale. 2005. Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41:1114-1122.
19. Moses, A. E., S. Goldberg, Z. Korenman, M. Ravins, E. Hanski, and M. Shapiro. 2002. Invasive group A streptococcal infections, Israel. Emerg. Infect. Dis. 8:421-426.
20. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson., and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases. Clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88:2668-2672.
21. National Committee for Clinical Laboratory Standards. 2002. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards, 5th ed. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. O'Brien, K. L., B. Beall, N. L. Barrett, P. R. Cieslak, A. Reingold, M. M. Farley, R. Danila, E. R. Zell, R. Facklam, B. Schwartz, and A. Schuchat. 2002. Epidemiology of invasive group A Streptococcus disease in United States, 1995-1999. Clin. Infect. Dis. 35:268-276.
23. Shulman, S. T., R. R. Tanz, W. Kabat, K. Kabat, E. Cederlund, D. Patal, Z. Li, V. Sakota, J. B. Dale, B. Beal, and U.S. Streptococcal Surveillance Group. 2004. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin. Infect. Dis. 39:325-332.
24. Stanley, J., D. Linton, M. Desai, A. Efstratiou, and R. George. 1995. Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. J. Clin. Microbiol. 33:2850-2855.
25. Stevens, D. L. 1992. Invasive group A streptococcus infections. Clin. Infect. Dis. 14:2-13.
26. Svensson, N., S. Öberg, B. Henriques, S. Holm, G. Källenius, V. Romanus, and J. Giesecke. 2000. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand. J. Infect. Dis. 32:609-614.
27. Szczypa, K., E. Sadowy, R. Izdebski, and W. Hryniewicz. 2004. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J. Antimicrob. Chemother. 54:828-831.
28. Tyler, S. D., W. M. Johnson, J. C. Huang, F. E. Ashton, G. Wang, D. E. Low, and K. R. Rozee. 1992. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J. Clin. Microbiol. 30:3127-3131.
29. Tyrrell, G., M. Lovgren, B. Forwick, N. P. Hoe, J. M. Musser, and J. A. Talbot. 2002. M types of group A streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J. Clin. Microbiol. 40:4466-4471.
30. Vlaminckx, B. J. M., E. M. Mascini, J. Schellekens, L. M. Schouls, A. Paauw, A. C. Fluit, R. Novak, J. Verhoef, and F. J. Schmitz. 2003. Site-specific manifestations of invasive group A streptococcal disease: type distribution and corresponding patterns of virulence determinants produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 41:4941-4949.
31. The Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. JAMA 269:390-391.
32. Zurawski, C. A., M. S. Bardsley, B. Beall, J. A. Elliott, R. Facklam, B. Schwartz, and M. M. Farley. 1998. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin. Infect. Dis. 27:150-157.